Certolizumab pegol is a prescription drug licensed for the treatment of Crohn's disease. This part of the eMedTV library explains how this medication works, describes its effects, and offers helpful dosing information.
Common side effects of certolizumab pegol include urinary tract infections, joint pain, and the common cold. This eMedTV segment also lists rare side effects, as well as potentially serious problems that require medical attention.
As this part of the eMedTV Web site explains, certolizumab pegol is used for relieving the signs and symptoms of Crohn's disease in adults. This article describes how this medication works for Crohn's and discusses possible off-label uses of the drug.
The recommended starting certolizumab pegol dosage is 400 mg every two weeks for three doses. As this eMedTV Web page explains, after that (if you respond well to the medicine), the recommended maintenance dose is 400 mg every four weeks.
Live vaccinations (such as the chickenpox vaccine) can cause drug interactions with certolizumab pegol. This eMedTV resource explains what other products may lead to interactions and describes the potential effects of these interactions.
Certolizumab pegol can increase your chance of infections, including serious infections. This eMedTV article contains more precautions and warnings with certolizumab pegol, including a list of other possible side effects or complications of the drug.
